1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.3 Market by Application 1.3.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Lung 1.3.3 Breast 1.3.4 Colorectal 1.3.5 Melanoma 1.3.6 Prostate 1.3.7 Head and Neck 1.3.8 Ovarian 1.3.9 Pancreatic 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Perspective (2016-2027) 2.2 Cancer Immunotherapy Drug Discovery Outsourcing Growth Trends by Regions 2.2.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Share by Regions (2016-2021) 2.2.3 Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Regions (2022-2027) 2.3 Cancer Immunotherapy Drug Discovery Outsourcing Industry Dynamic 2.3.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Trends 2.3.2 Cancer Immunotherapy Drug Discovery Outsourcing Market Drivers 2.3.3 Cancer Immunotherapy Drug Discovery Outsourcing Market Challenges 2.3.4 Cancer Immunotherapy Drug Discovery Outsourcing Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Cancer Immunotherapy Drug Discovery Outsourcing Players by Revenue 3.1.1 Global Top Cancer Immunotherapy Drug Discovery Outsourcing Players by Revenue (2016-2021) 3.1.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Players (2016-2021) 3.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Cancer Immunotherapy Drug Discovery Outsourcing Revenue 3.4 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Concentration Ratio 3.4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Cancer Immunotherapy Drug Discovery Outsourcing Revenue in 2020 3.5 Cancer Immunotherapy Drug Discovery Outsourcing Key Players Head office and Area Served 3.6 Key Players Cancer Immunotherapy Drug Discovery Outsourcing Product Solution and Service 3.7 Date of Enter into Cancer Immunotherapy Drug Discovery Outsourcing Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Cancer Immunotherapy Drug Discovery Outsourcing Breakdown Data by Type 4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Size by Type (2016-2021) 4.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Type (2022-2027) 5 Cancer Immunotherapy Drug Discovery Outsourcing Breakdown Data by Application 5.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Size by Application (2016-2021) 5.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2016-2027) 6.2 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type 6.2.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2021) 6.2.2 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2022-2027) 6.2.3 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2027) 6.3 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application 6.3.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2016-2021) 6.3.2 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2022-2027) 6.3.3 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2016-2027) 6.4 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country 6.4.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2016-2021) 6.4.2 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2016-2027) 7.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type 7.2.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2021) 7.2.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2022-2027) 7.2.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2027) 7.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application 7.3.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2016-2021) 7.3.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2022-2027) 7.3.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2016-2027) 7.4 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country 7.4.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2016-2021) 7.4.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2016-2027) 8.2 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type 8.2.1 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2027) 8.3 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application 8.3.1 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2016-2027) 8.4 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region 8.4.1 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2016-2027) 9.2 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type 9.2.1 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2021) 9.2.2 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2022-2027) 9.2.3 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2027) 9.3 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application 9.3.1 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2016-2021) 9.3.2 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2022-2027) 9.3.3 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2016-2027) 9.4 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country 9.4.1 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2016-2021) 9.4.2 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2016-2027) 10.2 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type 10.2.1 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2027) 10.3 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application 10.3.1 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2016-2027) 10.4 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country 10.4.1 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Aquila BioMedical 11.1.1 Aquila BioMedical Company Details 11.1.2 Aquila BioMedical Business Overview 11.1.3 Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Introduction 11.1.4 Aquila BioMedical Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) 11.1.5 Aquila BioMedical Recent Development 11.2 BPS Bioscience, Inc. 11.2.1 BPS Bioscience, Inc. Company Details 11.2.2 BPS Bioscience, Inc. Business Overview 11.2.3 BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction 11.2.4 BPS Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) 11.2.5 BPS Bioscience, Inc. Recent Development 11.3 Celentyx Ltd 11.3.1 Celentyx Ltd Company Details 11.3.2 Celentyx Ltd Business Overview 11.3.3 Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Introduction 11.3.4 Celentyx Ltd Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) 11.3.5 Celentyx Ltd Recent Development 11.4 Crown Bioscience, Inc. 11.4.1 Crown Bioscience, Inc. Company Details 11.4.2 Crown Bioscience, Inc. Business Overview 11.4.3 Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction 11.4.4 Crown Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) 11.4.5 Crown Bioscience, Inc. Recent Development 11.5 DiscoverX Corporation 11.5.1 DiscoverX Corporation Company Details 11.5.2 DiscoverX Corporation Business Overview 11.5.3 DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Introduction 11.5.4 DiscoverX Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) 11.5.5 DiscoverX Corporation Recent Development 11.6 Explicyte 11.6.1 Explicyte Company Details 11.6.2 Explicyte Business Overview 11.6.3 Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Introduction 11.6.4 Explicyte Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) 11.6.5 Explicyte Recent Development 11.7 Genscript Biotech Corporation 11.7.1 Genscript Biotech Corporation Company Details 11.7.2 Genscript Biotech Corporation Business Overview 11.7.3 Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Introduction 11.7.4 Genscript Biotech Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) 11.7.5 Genscript Biotech Corporation Recent Development 11.8 HD Biosciences Co. 11.8.1 HD Biosciences Co. Company Details 11.8.2 HD Biosciences Co. Business Overview 11.8.3 HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Introduction 11.8.4 HD Biosciences Co. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) 11.8.5 HD Biosciences Co. Recent Development 11.9 Horizon Discovery Group PLC 11.9.1 Horizon Discovery Group PLC Company Details 11.9.2 Horizon Discovery Group PLC Business Overview 11.9.3 Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Introduction 11.9.4 Horizon Discovery Group PLC Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) 11.9.5 Horizon Discovery Group PLC Recent Development 11.10 ImmunXperts SA 11.10.1 ImmunXperts SA Company Details 11.10.2 ImmunXperts SA Business Overview 11.10.3 ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Introduction 11.10.4 ImmunXperts SA Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) 11.10.5 ImmunXperts SA Recent Development 11.11 Molecular Imaging, Inc. 11.11.1 Molecular Imaging, Inc. Company Details 11.11.2 Molecular Imaging, Inc. Business Overview 11.11.3 Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction 11.11.4 Molecular Imaging, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) 11.11.5 Molecular Imaging, Inc. Recent Development 11.12 Promega Corporation,Personalis, Inc. 11.12.1 Promega Corporation,Personalis, Inc. Company Details 11.12.2 Promega Corporation,Personalis, Inc. Business Overview 11.12.3 Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction 11.12.4 Promega Corporation,Personalis, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) 11.12.5 Promega Corporation,Personalis, Inc. Recent Development 11.13 STC Biologics 11.13.1 STC Biologics Company Details 11.13.2 STC Biologics Business Overview 11.13.3 STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Introduction 11.13.4 STC Biologics Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) 11.13.5 STC Biologics Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 3. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 4. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Regions (2016-2021) & (US$ Million) Table 5. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Regions (2016-2021) Table 6. Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 7. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Regions (2022-2027) Table 8. Cancer Immunotherapy Drug Discovery Outsourcing Market Trends Table 9. Cancer Immunotherapy Drug Discovery Outsourcing Market Drivers Table 10. Cancer Immunotherapy Drug Discovery Outsourcing Market Challenges Table 11. Cancer Immunotherapy Drug Discovery Outsourcing Market Restraints Table 12. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Players (2016-2021) & (US$ Million) Table 13. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Players (2016-2021) Table 14. Global Top Cancer Immunotherapy Drug Discovery Outsourcing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Immunotherapy Drug Discovery Outsourcing as of 2020) Table 15. Ranking of Global Top Cancer Immunotherapy Drug Discovery Outsourcing Companies by Revenue (US$ Million) in 2020 Table 16. Global 5 Largest Players Market Share by Cancer Immunotherapy Drug Discovery Outsourcing Revenue (CR5 and HHI) & (2016-2021) Table 17. Key Players Headquarters and Area Served Table 18. Key Players Cancer Immunotherapy Drug Discovery Outsourcing Product Solution and Service Table 19. Date of Enter into Cancer Immunotherapy Drug Discovery Outsourcing Market Table 20. Mergers & Acquisitions, Expansion Plans Table 21. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2021) (US$ Million) Table 22. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Type (2016-2021) Table 23. Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Type (2022-2027) (US$ Million) Table 24. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Type (2022-2027) & (US$ Million) Table 25. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Share by Application (2016-2021) & (US$ Million) Table 26. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Application (2016-2021) Table 27. Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Application (2022-2027) (US$ Million) Table 28. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Application (2022-2027) & (US$ Million) Table 29. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2021) (US$ Million) Table 30. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2022-2027) & (US$ Million) Table 31. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2016-2021) (US$ Million) Table 32. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2022-2027) & (US$ Million) Table 33. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2016-2021) & (US$ Million) Table 34. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2022-2027) & (US$ Million) Table 35. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2021) (US$ Million) Table 36. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2022-2027) & (US$ Million) Table 37. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2016-2021) (US$ Million) Table 38. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2022-2027) & (US$ Million) Table 39. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2016-2021) & (US$ Million) Table 40. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2022-2027) & (US$ Million) Table 41. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2021) (US$ Million) Table 42. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2022-2027) & (US$ Million) Table 43. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2016-2021) (US$ Million) Table 44. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2022-2027) & (US$ Million) Table 45. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (2016-2021) & (US$ Million) Table 46. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (2022-2027) & (US$ Million) Table 47. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2021) (US$ Million) Table 48. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2022-2027) & (US$ Million) Table 49. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2016-2021) (US$ Million) Table 50. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2022-2027) & (US$ Million) Table 51. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2016-2021) & (US$ Million) Table 52. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2022-2027) & (US$ Million) Table 53. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2021) (US$ Million) Table 54. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2022-2027) & (US$ Million) Table 55. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2016-2021) (US$ Million) Table 56. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2022-2027) & (US$ Million) Table 57. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2016-2021) & (US$ Million) Table 58. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2022-2027) & (US$ Million) Table 59. Aquila BioMedical Company Details Table 60. Aquila BioMedical Business Overview Table 61. Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Product Table 62. Aquila BioMedical Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) & (US$ Million) Table 63. Aquila BioMedical Recent Development Table 64. BPS Bioscience, Inc. Company Details Table 65. BPS Bioscience, Inc. Business Overview Table 66. BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product Table 67. BPS Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) & (US$ Million) Table 68. BPS Bioscience, Inc. Recent Development Table 69. Celentyx Ltd Company Details Table 70. Celentyx Ltd Business Overview Table 71. Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Product Table 72. Celentyx Ltd Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) & (US$ Million) Table 73. Celentyx Ltd Recent Development Table 74. Crown Bioscience, Inc. Company Details Table 75. Crown Bioscience, Inc. Business Overview Table 76. Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product Table 77. Crown Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) & (US$ Million) Table 78. Crown Bioscience, Inc. Recent Development Table 79. DiscoverX Corporation Company Details Table 80. DiscoverX Corporation Business Overview Table 81. DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Product Table 82. DiscoverX Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) & (US$ Million) Table 83. DiscoverX Corporation Recent Development Table 84. Explicyte Company Details Table 85. Explicyte Business Overview Table 86. Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Product Table 87. Explicyte Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) & (US$ Million) Table 88. Explicyte Recent Development Table 89. Genscript Biotech Corporation Company Details Table 90. Genscript Biotech Corporation Business Overview Table 91. Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Product Table 92. Genscript Biotech Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) & (US$ Million) Table 93. Genscript Biotech Corporation Recent Development Table 94. HD Biosciences Co. Company Details Table 95. HD Biosciences Co. Business Overview Table 96. HD Biosciences Co. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) & (US$ Million) Table 97. HD Biosciences Co. Recent Development Table 98. Horizon Discovery Group PLC Company Details Table 99. Horizon Discovery Group PLC Business Overview Table 100. Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Product Table 101. Horizon Discovery Group PLC Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) & (US$ Million) Table 102. Horizon Discovery Group PLC Recent Development Table 103. ImmunXperts SA Company Details Table 104. ImmunXperts SA Business Overview Table 105. ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Product Table 106. ImmunXperts SA Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) & (US$ Million) Table 107. ImmunXperts SA Recent Development Table 108. Molecular Imaging, Inc. Company Details Table 109. Molecular Imaging, Inc. Business Overview Table 110. Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product Table 111. Molecular Imaging, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) & (US$ Million) Table 112. Molecular Imaging, Inc. Recent Development Table 113. Promega Corporation,Personalis, Inc. Company Details Table 114. Promega Corporation,Personalis, Inc. Business Overview Table 115. Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product Table 116. Promega Corporation,Personalis, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) & (US$ Million) Table 117. Promega Corporation,Personalis, Inc. Recent Development Table 118. STC Biologics Company Details Table 119. STC Biologics Business Overview Table 120. STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Product Table 121. STC Biologics Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) & (US$ Million) Table 122. STC Biologics Recent Development Table 123. Research Programs/Design for This Report Table 124. Key Data Information from Secondary Sources Table 125. Key Data Information from Primary Sources List of Figures Figure 1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type: 2020 VS 2027 Figure 4. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application: 2020 VS 2027 Figure 5. Lung Case Studies Figure 6. Breast Case Studies Figure 7. Colorectal Case Studies Figure 8. Melanoma Case Studies Figure 9. Prostate Case Studies Figure 10. Head and Neck Case Studies Figure 11. Ovarian Case Studies Figure 12. Pancreatic Case Studies Figure 13. Cancer Immunotherapy Drug Discovery Outsourcing Report Years Considered Figure 14. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 15. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Regions: 2020 VS 2027 Figure 17. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Regions (2022-2027) Figure 18. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Players in 2020 Figure 19. Global Top Cancer Immunotherapy Drug Discovery Outsourcing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Immunotherapy Drug Discovery Outsourcing as of 2020 Figure 20. The Top 10 and 5 Players Market Share by Cancer Immunotherapy Drug Discovery Outsourcing Revenue in 2020 Figure 21. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Type (2016-2021) Figure 22. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Type (2022-2027) Figure 23. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2016-2027) Figure 25. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2016-2027) Figure 26. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Country (2016-2027) Figure 27. United States Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2016-2027) Figure 31. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2016-2027) Figure 32. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Country (2016-2027) Figure 33. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. France Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. U.K. Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Italy Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Russia Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Nordic Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2016-2027) Figure 41. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2016-2027) Figure 42. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Region (2016-2027) Figure 43. China Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. India Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Australia Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2016-2027) Figure 51. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2016-2027) Figure 52. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Country (2016-2027) Figure 53. Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2016-2027) Figure 57. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2016-2027) Figure 58. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Country (2016-2027) Figure 59. Turkey Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. UAE Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. Aquila BioMedical Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) Figure 63. BPS Bioscience, Inc. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) Figure 64. Celentyx Ltd Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) Figure 65. Crown Bioscience, Inc. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) Figure 66. DiscoverX Corporation Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) Figure 67. Explicyte Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) Figure 68. Genscript Biotech Corporation Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) Figure 69. HD Biosciences Co. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) Figure 70. Horizon Discovery Group PLC Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) Figure 71. ImmunXperts SA Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) Figure 72. Molecular Imaging, Inc. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) Figure 73. Promega Corporation,Personalis, Inc. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) Figure 74. STC Biologics Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) Figure 75. Bottom-up and Top-down Approaches for This Report Figure 76. Data Triangulation Figure 77. Key Executives Interviewed

Aquila BioMedical BPS Bioscience, Inc. Celentyx Ltd Crown Bioscience, Inc. DiscoverX Corporation Explicyte Genscript Biotech Corporation HD Biosciences Co. Horizon Discovery Group PLC ImmunXperts SA Molecular Imaging, Inc. Promega Corporation,Personalis, Inc. STC Biologics